WallStSmart

Andersen Group Inc. (ANDG)vsMEDIFAST INC (MED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Andersen Group Inc. generates 188% more annual revenue ($913.04M vs $316.93M). ANDG leads profitability with a 4.7% profit margin vs -8.1%. MED earns a higher WallStSmart Score of 45/100 (D).

ANDG

Avoid

32

out of 100

Grade: F

Growth: 6.7Profit: 4.5Value: 4.0Quality: 6.0
Piotroski: 2/9Altman Z: 0.88

MED

Hold

45

out of 100

Grade: D

Growth: 2.0Profit: 2.0Value: 6.0Quality: 8.5
Piotroski: 2/9Altman Z: 5.09

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ANDG2 strengths · Avg: 9.0/10
Debt/EquityHealth
-0.5310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
23.7%8/10

Revenue surging 23.7% year-over-year

MED4 strengths · Avg: 9.3/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
5.0910/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.978/10

Growing faster than its price suggests

Areas to Watch

ANDG4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
119.2x2/10

Premium valuation, high expectations priced in

MED4 concerns · Avg: 2.5/10
Market CapQuality
$141.66M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-10.1%2/10

ROE of -10.1% — below average capital efficiency

Revenue GrowthGrowth
-27.6%2/10

Revenue declined 27.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : ANDG

The strongest argument for ANDG centers on Debt/Equity, Revenue Growth. Revenue growth of 23.7% demonstrates continued momentum.

Bull Case : MED

The strongest argument for MED centers on Price/Book, Altman Z-Score, Debt/Equity. PEG of 0.97 suggests the stock is reasonably priced for its growth.

Bear Case : ANDG

The primary concerns for ANDG are EPS Growth, Profit Margin, Piotroski F-Score. A P/E of 119.2x leaves little room for execution misses. Thin 4.7% margins leave little buffer for downturns.

Bear Case : MED

The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

ANDG profiles as a growth stock while MED is a turnaround play — different risk/reward profiles.

ANDG is growing revenue faster at 23.7% — sustainability is the question.

ANDG generates stronger free cash flow (61M), providing more financial flexibility.

Monitor PERSONAL SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MED scores higher overall (45/100 vs 32/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Andersen Group Inc.

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Andersen Group Inc. provides independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States.

MEDIFAST INC

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.

Visit Website →

Want to dig deeper into these stocks?